No EU Fast Track for AZ’s Imfinzi In Stage III Lung Cancer

 
• By Maureen Kenny
Darts
AstraZeneca missed its target of getting EU speedy review for Infimzi • Source: Shutterstock

More from Immuno-oncology

More from Anticancer